| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.026 | 0.9 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0074 | 0.9 |